Skip to main content
. 2014 Dec 10;6(4):2009–2022. doi: 10.18632/oncotarget.2987

Table 1. Distribution of TKRs expression in TMA.

Tumor Biomarker Score
HER3
FGFR2 0 1 2 3 Total (n)
0 15 2 0 0 17
1 11 13 18 1 43
2 22 20 22 4 68
3 5 5 10 7 27
Total (n) 43 40 50 12 145
MET
FGFR2 0 1 2 3 Total (n)
0 17 0 0 0 17
1 18 11 1 3 33
2 32 26 6 4 68
3 12 9 6 0 27
Total (n) 79 46 13 7 145
EGFR
FGFR2 0 1 2 3 Total (n)
0 12 5 0 0 17
1 25 8 0 0 33
2 19 18 20 1 58
3 8 12 5 2 27
Total (n) 64 43 25 3 145

Summary of FGFR2, HER3, EGFR and MET status in gastric cancer tissue microarray (n = 145 primary gastric cancer surgical samples). TKR, tyrosine kinase receptor; TMA, tissue microarray analysis; FGFR2, fibroblast growth factor receptor 2; EGFR, epidermal growth factor receptor; HER3, human epidermal growth factor receptor 3.